Everyone has an endocannabinoid system, which plays a vital role in inflammation and neuroprotection. In the ocular tissue of our eyes, we have CB1 cannabinoid (CBD) receptors that play a part in controlling intraocular pressure (IOP). Recent research suggests hemp CBD can help Glaucoma patients.
Many scientists and researchers believe that our endocannabinoid system would benefit from CBD, as well as our cannabinoid receptors. Many experimental and clinical studies have been conducted around the world to find a link between CBD and Glaucoma. It has been challenging to research hemp in the U.S. because it was considered illegal until the passing of the 2018 Farm Bill.
A great many studies discovered that CBD could be a natural approach to treating Glaucoma. A study performed by professors from the University of Aberdeen demonstrated how cannabinoids like CBD could relieve the symptoms of Glaucoma. Also, Cannabinoids effectively lowered the IOP (intraocular pressure) and provided neuroprotective properties.
Another study found that taking cannabis would reduce IOP by 30% – 35%. Both of the studies indicate that patients can treat their Glaucoma conditions by consuming CBD products. Finally, a few studies conducted in the United States and Europe on the use of CBD for Glaucoma treatment shows favorable results. Also, a lot of these studies prove cannabinoids such as CBD can productively lower IOP when you administer it topically.
In conclusion, ophthalmologists these days are recommending their patients take CBD products rather than cannabis alone. Specifically, people in the mid-late stages of Glaucoma.